Targeting and Efficacy of Novel mAb806-Antibody-Drug Conjugates in Malignant Mesothelioma

Targeting and Efficacy of Novel mAb806-Antibody-Drug Conjugates in Malignant Mesothelioma

Epidermal growth factor receptor (EGFR) is highly overexpressed in malignant mesothelioma (MM). MAb806 is a novel anti-EGFR antibody that selectively targets a tumor-selective epitope. MAb806-derived antibody drug conjugates (ADCs), ABT-414, ABBV-221 and ABBV-322, may represent a novel therapeutic s...

Full description

Saved in:
Bibliographic Details
Main Authors: Puey-Ling Chia (Author), Sagun Parakh (Author), Ming-Sound Tsao (Author), Nhu-An Pham (Author), Hui K. Gan (Author), Diana Cao (Author), Ingrid J. G. Burvenich (Author), Angela Rigopoulos (Author), Edward B. Reilly (Author), Thomas John (Author), Andrew M. Scott (Author)
Format: Book
Published: MDPI AG, 2020-10-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items